An Alzheimer's vaccine called AD02 has proceeded to Phase II clinical trials, experts say. A total of 420 patients in five European countries will be involved in the study. Currently, the results of the Phase I results of the study is confidential, but the safety of the drug has already been established, so experts say this second phase will help determine its effectiveness.
Researchers at the University of California, Irvine, have been testing a promising vaccine designed to clear beta-amyloid plaques from the... Read more »
Immunotherapy for Alzheimer's disease, commonly known as "the Alzheimer's Vaccine" has generated considerable excitement in both the... Read more »
I hope everyone had a pleasant Labor Day, and has had a wonderful summer. I'll be finishing the summer's blogs with some more good news... Read more »
November is National Alzheimer's Disease Awareness Month and National Family Caregivers Month. Check the websties of the National... Read more »
The International Conference on Alzheimer’s disease (ICAD) will be held in Chicago on July 26-31. Generally regarded as the premiere... Read more »
A study to determine the effectiveness of an Alzheimer's vaccine is being resumed in Great Britain. The vaccine, known as AN-1792, is designed to... Read more »
Korean researchers say the tomato may be a suitable carrier for a vaccine against Alzheimer's. In a recent study, scientists combined a tomato's... Read more »
Source: ADAM Encyclopedia
Senile dementia - Alzheimer's type (SDAT); SDATPreventionAlthough there is no proven way to prevent AD, there are some practices that may be worth... Read more »
An Alzheimer's vaccine may one day be available as a skin patch, new research suggests. Researchers at the University of South Florida say that the... Read more »
Studies published in a recent issue of The Lancet are reporting both good news and bad news from scientists involved in Alzheimer's research. In one... Read more »